+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Forecast 2024-2030- Product Image
Global Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Forecast 2024-2030- Product Image
Sale

Global Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887504
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glucosamine Market size was estimated at USD 800.48 million in 2023, USD 841.71 million in 2024, and is expected to grow at a CAGR of 5.28% to reach USD 1,147.62 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Glucosamine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Glucosamine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Types
    • Glucosamine Hydrochloride
    • Glucosamine Sulfate Potassium Chloride
    • Glucosamine Sulfate Sodium Chloride
    • N-Acetylglucosamine
  • Form
    • Capsules
    • Liquid
    • Powder
    • Tablets
  • Source
    • Animal
      • Crab
      • Lobster
      • Shrimp
    • Plant
      • Corn
      • Mushrooom
  • Application
    • Cosmetics
    • Dietary Supplements
    • Health Food
    • Medicine
    • Veterinary
  • Distribution Channel
    • Online Stores
    • Pharmacies
    • Retail Stores
    • Supermarkets
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Glucosamine Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Glucosamine Market?
  3. What are the technology trends and regulatory frameworks in the Glucosamine Market?
  4. What is the market share of the leading vendors in the Glucosamine Market?
  5. Which modes and strategic moves are suitable for entering the Glucosamine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Glucosamine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
5.1.2. Restraints
5.1.2.1. High cost related to glucosamine products
5.1.3. Opportunities
5.1.3.1. Launch and approval of novel glucosamine products
5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
5.1.4. Challenges
5.1.4.1. Several side effects associated with glucosamine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Glucosamine Market, by Types
6.1. Introduction
6.2. Glucosamine Hydrochloride
6.3. Glucosamine Sulfate Potassium Chloride
6.4. Glucosamine Sulfate Sodium Chloride
6.5. N-Acetylglucosamine
7. Glucosamine Market, by Form
7.1. Introduction
7.2. Capsules
7.3. Liquid
7.4. Powder
7.5. Tablets
8. Glucosamine Market, by Source
8.1. Introduction
8.2. Animal
8.3.1. Crab
8.3.2. Lobster
8.3.3. Shrimp
8.3. Plant
8.4.1. Corn
8.4.2. Mushrooom
9. Glucosamine Market, by Application
9.1. Introduction
9.2. Cosmetics
9.3. Dietary Supplements
9.4. Health Food
9.5. Medicine
9.6. Veterinary
10. Glucosamine Market, by Distribution Channel
10.1. Introduction
10.2. Online Stores
10.3. Pharmacies
10.4. Retail Stores
10.5. Supermarkets
11. Americas Glucosamine Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Glucosamine Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Glucosamine Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Aden Healthcare
15.1.2. Andra Medi Pharma India Pvt. Ltd.
15.1.3. Bio-gen Extracts Pvt. Ltd.
15.1.4. Captek Softgel International Inc.
15.1.5. Cargill, Inc.
15.1.6. Cellmark AB
15.1.7. Enomark Pharma
15.1.8. Ethical Naturals Inc.
15.1.9. Fabrichem, Inc.
15.1.10. Fermentis Life Sciences
15.1.11. GlucosaGreen
15.1.12. Golden Shell Pharmaceutical Co. Ltd.
15.1.13. Kabir Lifesciences
15.1.14. Koyo Chemical Co., Ltd.
15.1.15. Lifecare Neuro Products Limited
15.1.16. Manus Aktteva Biopharma LLP
15.1.17. Panvo Organics Pvt Ltd.
15.1.18. Pax Healthcare
15.1.19. Schiff Nutrition International Inc.
15.1.20. SMPNutra
15.1.21. Spectrum Chemical Manufacturing Corp.
15.1.22. TSI Health Sciences, Inc.
15.1.23. United Laboratories, Inc.
15.1.24. Velnex Medicare
15.1.25. Wellable Marine Biotech Holding Limited
15.1.26. Zhejiang AOXING Biotechnology Co., Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLUCOSAMINE MARKET DYNAMICS
FIGURE 7. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
FIGURE 8. GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 16. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 6. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLUCOSAMINE MARKET SIZE, BY N-ACETYLGLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 11. GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 16. GLUCOSAMINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 18. GLUCOSAMINE MARKET SIZE, BY CRAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLUCOSAMINE MARKET SIZE, BY LOBSTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLUCOSAMINE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLUCOSAMINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 23. GLUCOSAMINE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLUCOSAMINE MARKET SIZE, BY MUSHROOOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLUCOSAMINE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLUCOSAMINE MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLUCOSAMINE MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLUCOSAMINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLUCOSAMINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLUCOSAMINE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLUCOSAMINE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 59. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. CANADA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 62. CANADA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 63. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 70. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CHINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 96. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. CHINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 99. CHINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 100. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. INDIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 103. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. INDIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 106. INDIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 107. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 117. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 118. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 120. JAPAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 121. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 159. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 160. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 162. THAILAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 163. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 184. DENMARK GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 185. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 188. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 189. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 191. EGYPT GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 192. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 199. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 202. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 203. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 205. FRANCE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 206. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 209. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 210. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 211. GERMANY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 212. GERMANY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 213. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. ITALY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 223. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 224. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. ITALY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 226. ITALY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 227. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 247. NORWAY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 248. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. POLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 251. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 254. POLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 255. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. QATAR GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 258. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 259. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 260. QATAR GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 261. QATAR GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 262. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 287. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 289. SPAIN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 290. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 307. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 308. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 309. TURKEY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 310. TURKEY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 311. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 328. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 329. GLUCOSAMINE MARKET LICENSE & PRICING

Companies Mentioned

  • Aden Healthcare
  • Andra Medi Pharma India Pvt. Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Captek Softgel International Inc.
  • Cargill, Inc.
  • Cellmark AB
  • Enomark Pharma
  • Ethical Naturals Inc.
  • Fabrichem, Inc.
  • Fermentis Life Sciences
  • GlucosaGreen
  • Golden Shell Pharmaceutical Co. Ltd.
  • Kabir Lifesciences
  • Koyo Chemical Co., Ltd.
  • Lifecare Neuro Products Limited
  • Manus Aktteva Biopharma LLP
  • Panvo Organics Pvt Ltd.
  • Pax Healthcare
  • Schiff Nutrition International Inc.
  • SMPNutra
  • Spectrum Chemical Manufacturing Corp.
  • TSI Health Sciences, Inc.
  • United Laboratories, Inc.
  • Velnex Medicare
  • Wellable Marine Biotech Holding Limited
  • Zhejiang AOXING Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 841.71 Million
Forecasted Market Value ( USD ) by 2030 $ 1147.62 Million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Global Global Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Global Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Glucosamine Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031 - Product Image

Glucosamine Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031

  • Report
  • 156 Pages
  • Global
From
Glucosamine: Global Strategic Business Report - Product Image

Glucosamine: Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From
Glucosamine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Glucosamine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Glucosamine Salt Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Glucosamine Salt Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 99 Pages
  • Global
From

About the Market

Glucosamine is a naturally occurring compound found in the human body and is used in the treatment of immune disorders. It is used to reduce inflammation and pain associated with these disorders, as well as to improve joint mobility. Glucosamine is available in both oral and topical forms, and is often combined with other drugs to increase its effectiveness. It is also used in combination with other drugs to treat autoimmune diseases such as rheumatoid arthritis, lupus, and psoriasis. Glucosamine is a popular supplement for those suffering from immune disorders, as it is generally considered safe and effective. It is also widely available over the counter, making it an attractive option for those looking for an alternative to prescription medications. The glucosamine market is highly competitive, with many companies offering products that contain the compound. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Other companies that offer glucosamine products include Nature's Bounty, Schiff, and Solgar. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.